Baekje Shenzhou: Phase 3 RATIONALE 315 trial of tirelizumab combined with chemotherapy for resectable NSCLC achieved its primary endpoint of MPR and EFS
芊芊551
发表于 2023-10-22 12:11:47
293
0
0
On October 22nd, the Baekje Shenzhou official announced that the Phase 3 clinical trial of Tirelizumab combined with chemotherapy for resectable NSCLC achieved its primary endpoints of MPR and EFS in the Phase 3 RATIONALE 315 trial. The Phase 3 clinical trial achieved its dual primary endpoints: primary pathological response (MPR) evaluated by blind independent pathological review (BIPR) and event free survival (EFS) evaluated by blind independent center review (BICR). Compared with placebo combined chemotherapy as a neoadjuvant treatment and receiving placebo treatment after surgery, resectable stage II or IIIA non-small cell lung cancer (NSCLC) patients who received tirolizumab combined chemotherapy before surgery and tirolizumab monotherapy after surgery showed statistically significant and clinically significant improvements. After neoadjuvant therapy, the combination of tirelizumab and chemotherapy also showed statistically significant improvement in pathological complete response (pCR) in the key secondary endpoint compared to chemotherapy alone.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Tesla China: Buy Model Y and get a 10000 yuan discount on the final payment of the current car
- Tesla China launches policy of "immediate reduction of final payment for current car purchases"
- KFC China raises prices by 2%
- Amazon Web Services re: Invent 2024 China Tour: Based on Practical AI, Capturing Different Scenario Needs
- The spokesperson of the Ministry of Commerce issued a statement on the US's 301 investigation into China's chip industry related policies
- The Nasdaq China Golden Dragon Index closed up 0.79%, while Fangduoduo rose over 5%
- The Nasdaq China Golden Dragon Index closed up 0.42%, while Fangduoduo rose nearly 13%
- Yihang Intelligence collaborates with China Communications Information Technology Group to jointly layout and construct low altitude industrial ecosystems such as air traffic digital and ground infrastructure
- Lincoln China responds to rumors of Lincoln merging with Ford China, NIO Ledo L60 delivers over 20000 vehicles
- Most popular Chinese concept stocks in the US stock market closed down, while the Nasdaq China Golden Dragon Index fell 1.9%